Le Lézard
Classified in: Health, Covid-19 virus
Subjects: SVY, POL

New National Poll Finds Strong Support for Medicare Home Health Services, Preserving Access to Home Health Act


Medicare beneficiaries overwhelmingly support policies to protect access to Medicare home health

WASHINGTON, Aug. 17, 2022 /PRNewswire/ -- The Partnership for Quality Home Healthcare (the Partnership) today announced the results of a newly conducted national public opinion poll on the Medicare Home Health Program. The poll found widespread and deep support for Medicare home health care services and the need to prevent Medicare cuts to home healthcare.

The poll, conducted by Morning Consult on behalf of the Partnership, found that nearly all Medicare beneficiaries (97 percent) want the federal government to maintain Medicare coverage for at-home health care services and nine in ten (88 percent) believe it is important for Congress to pass legislation that would prevent the Centers for Medicare & Medicaid Services' (CMS) proposed cuts to Medicare home health services.

Other key findings from the poll include:

"The American people have made it clear that they overwhelmingly support and prefer home health care services. We must continue to protect access for Medicare beneficiaries by preventing these vital services from facing permanent and temporary reductions as proposed in the CY 2023 Prospective Payment System," said Joanne Cunningham, CEO of the Partnership. "I hope lawmakers in Congress listen to the voters and quickly pass the Preserving Access to Home Health Act (H.R. 8581/S.4605), which will ensure that the Medicare Home Healthcare Program is preserved and protected. Without action, Medicare home health services are at severe risk."

The Partnership supports the bipartisan Preserving Access to Home Health Act, which if enacted will delay the proposed 7.69% cut from being implemented until 2026 and block an additional $2 billion "clawback" cut on services provided during the first two years of the COVID-19 pandemic from taking effect.

The poll was conducted by Morning Consult from July 22 to July 24, 2022, with a sample of 2,005 registered voters. The results have a margin of error of +/- 2 percent.

To learn more about Medicare's proposed cuts to home health, click here.

About the Partnership
The Partnership for Quality Home Healthcare represents community- and hospital-based home healthcare agencies across the U.S. and is dedicated to developing innovative reforms to improve the quality, efficiency and integrity of home healthcare. To learn more, visit www.pqhh.org.

SOURCE Partnership for Quality Home Healthcare


These press releases may also interest you

at 01:00
PARIS, FRANCE, 24 April 2024 - Ipsen (Euronext: IPN; ADR: IPSEY), a global specialty-care biopharmaceutical company, today presents its sales for the first quarter of 2024. ? ?  Q1 2024? Q1 2023? % change? ?m? ?m? ActualCER1Growth...

23 avr 2024
GenScript, a global leader in life sciences and biotechnology, successfully hosted an Open Day event at its Singapore facility on the 16th of April, welcoming more than 50 representatives from Singapore. This event provided an exclusive look into...

23 avr 2024
Cybervation, an award-winning global technology and healthcare solutions company, proudly announces that its CEO, Purba Majumder, has been distinguished as one of the 2024 100 Women to KNOW Across America. This award from KNOW Women recognizes...

23 avr 2024
The report titled "Glycated Albumin Assay Market by Product (Animal Glycated Albumin Assay, Human Glycated Albumin Assay), Application (Prediabetes, Type 1 Diabetes, Type 2 Diabetes), End User - Global Forecast 2024-2030" is now available on...

23 avr 2024
The report titled "Health & Wellness Food Market by Type (Fresh & Natural, Functional Foods & Beverages, Heat & Eat), Nature (Genetically Modified Organism Food, Non-Genetically Modified Organism Food), Fat Content, Category, Free From Category,...

23 avr 2024
Hanmi Pharmaceutical (KOSPI: 128940, CEO: Jae-Hyun Park), a leading biopharma company in Korea that focuses on research areas such as oncology, obesity/metabolism, and rare diseases, announced it has entered into a Clinical Trial Collaboration and...



News published on and distributed by: